The ISCCA flow protocol for the monitoring of anti‐CD20 therapies in autoimmune disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The ISCCA flow protocol for the monitoring of anti‐CD20 therapies in autoimmune disorders

Published:2020-06-29 Issue:2 Volume:100 Page:194-205
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Gatti Arianna¹,Buccisano Francesco²,Scupoli Maria T.³⁴,Brando Bruno¹^ORCID

Affiliation:

1. Hematology Laboratory and Transfusion Center Western Milan Area Hospital Consortium Legnano Milan Italy

2. Department of Biomedicine and Prevention, Hematology Tor Vergata University of Rome Rome Italy

3. Department of Neurosciences, Biomedicine and Movement Sciences University of Verona Verona Italy

4. Research Center LURM (Interdepartmental Laboratory of Medical Research) University of Verona Verona Italy

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21930

Reference82 articles.

1. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

2. TLR Ligation Triggers Somatic Hypermutation in Transitional B Cells Inducing the Generation of IgM Memory B Cells

3. Human B-cell memory is shaped by age- and tissue-specific T-independent and GC-dependent events

4. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

5. Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation;Cytometry Part B: Clinical Cytometry;2024-06-28

2. Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?;Expert Opinion on Pharmacotherapy;2024-06-12

3. Issue highlights—May 2024;Cytometry Part B: Clinical Cytometry;2024-05

4. Evaluation of analytical performance of AQUIOS CL flow cytometer and method comparison with bead-based flow cytometry methods;Clinical Chemistry and Laboratory Medicine (CCLM);2024-04-08

5. Immune monitoring of patients treated with anti-CD20 therapeutic monoclonals for autoimmune disorders;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3